Anticancer activity of Δ9-tetrahydrocannabinol and cannabinol in vitro and in human lung cancer xenograft
Asian Pacific Journal of Tropical Biomedicine · 2022-08 · 12 (8) · 323-332
DOI: 10.4103/2221-1691.350180 ↗Kurz gefasst
Fachartikel in der Zeitschrift Asian Pacific Journal of Tropical Biomedicine, 2022-08. Verfasst von Surang Leelawat und 9 weiteren Autor:innen. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
Objective
To investigate the effects of Δ 9 -tetrahydrocannabinol, the principal psychoactive compound of Cannabis sativa , and cannabinol, a Δ 9 -tetrahydrocannabinol degradative product, on human non-small cell lung cancer cells.
Methods
Δ 9 -Tetrahydrocannabinol and cannabinol were tested for anticancer activity in human non-small cell lung cancer (A549) cells. The effects on cell proliferation, apoptosis, and phosphorylation profiles were examined. The effects of Δ 9 -tetrahydrocannabinol and cannabinol on tumor growth were also investigated using a xenograft nude mouse model. Apoptosis and targeted phosphorylation were verified by immunohistochemistry.
Results
Δ 9 -Tetrahydrocannabinol and cannabinol significantly inhibited cell proliferation and increased the number of apoptotic cells in a concentration-dependent manner. The Δ 9 -tetrahydrocannabinol- and cannabinol-treated cells had lower levels of phosphorylated protein kinase B [AKT (S473)], glycogen synthase kinase 3 alpha/beta, and endothelial nitric oxide synthase compared to the controls. The study of xenograft mice revealed that tumors treated with 15 mg/kg Δ 9 -tetrahydrocannabinol or 40 mg/kg cannabinol were significantly smaller than those of the control mice. The tumor progression rates in mice treated with 15 mg/kg Δ 9 -tetrahydrocannabinol or 40 mg/kg cannabinol were significantly slower than in the control group.
Conclusions
These findings indicate that Δ 9 -tetrahydrocannabinol and cannabinol inhibit lung cancer cell growth by inhibiting AKT and its signaling pathways, which include glycogen synthase kinase 3 alpha/beta and endothelial nitric oxide synthase.
Zitieren
APA
Leelawat, S., Leelawat, K., Wannakup, T., Saingam, W., Khamthong, N., Madaka, F., Maha, A., Pathompak, P., Sueree, L., & Songsak, T. (2022). Anticancer activity of Δ9-tetrahydrocannabinol and cannabinol in vitro and in human lung cancer xenograft. Asian Pacific Journal of Tropical Biomedicine, 12(8), 323-332. https://doi.org/10.4103/2221-1691.350180
Vancouver
Leelawat S, Leelawat K, Wannakup T, Saingam W, Khamthong N, Madaka F, et al. Anticancer activity of Δ9-tetrahydrocannabinol and cannabinol in vitro and in human lung cancer xenograft. Asian Pacific Journal of Tropical Biomedicine. 2022;12(8):323-332. doi:10.4103/2221-1691.350180
BibTeX
@article{Leelawat2022,
author = {Leelawat, Surang and Leelawat, Kawin and Wannakup, Thaniya and Saingam, Worawan and Khamthong, Nanthaphong and Madaka, Fameera and Maha, Athip and Pathompak, Patamaporn and Sueree, Lukman and Songsak, Thanapat},
title = {Anticancer activity of Δ9-tetrahydrocannabinol and cannabinol in vitro and in human lung cancer xenograft},
journal = {Asian Pacific Journal of Tropical Biomedicine},
year = {2022},
volume = {12},
number = {8},
pages = {323--332},
doi = {10.4103/2221-1691.350180}
}
EUVIMED